{
    "organizations": [],
    "uuid": "a55d0eee8c1b560f155d569d566ded71a55f413b",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/04/24/business-wire-clovis-oncology-to-announce-first-quarter-2018-financial-results-and-host-webcast-conference-call-on-may-8.html",
    "ord_in_thread": 0,
    "title": "Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2018 financial results on Tuesday, May 8, 2018, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail.\nThe conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com . A replay of the webcast will be available for 30 days.\nConference Call Details\nClovis will hold a conference call to discuss first quarter 2018 results on May 8 at 4:30 p.m. ET. The conference call will be simultaneously webcast on the Company’s website at www.clovisoncology.com , and archived for future review. Dial-in numbers for the conference call are as follows: US participants 866.489.9022, International participants 678.509.7575, conference ID: 4198438 .\nAbout Clovis Oncology\nClovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK. Please visit clovisoncology.com for more information.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180424005367/en/\nClovis Oncology, Inc.\nInvestor Contacts:\nAnna Sussman, 303-625-5022\nasussman@clovisoncology.com\nor\nBreanna Burkart, 303-625-5023\nbburkart@clovisoncology.com\nSource: Clovis Oncology, Inc.",
    "published": "2018-04-25T00:15:00.000+03:00",
    "crawled": "2018-04-25T00:43:24.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "boulder",
        "business",
        "wire",
        "clovis",
        "oncology",
        "nasdaq",
        "clvs",
        "announce",
        "first",
        "quarter",
        "financial",
        "result",
        "tuesday",
        "may",
        "close",
        "financial",
        "market",
        "clovis",
        "senior",
        "management",
        "host",
        "conference",
        "call",
        "live",
        "audio",
        "webcast",
        "et",
        "discus",
        "company",
        "result",
        "greater",
        "detail",
        "conference",
        "call",
        "webcast",
        "accessed",
        "clovis",
        "oncology",
        "website",
        "replay",
        "webcast",
        "available",
        "day",
        "conference",
        "call",
        "detail",
        "clovis",
        "hold",
        "conference",
        "call",
        "discus",
        "first",
        "quarter",
        "result",
        "may",
        "et",
        "conference",
        "call",
        "simultaneously",
        "webcast",
        "company",
        "website",
        "archived",
        "future",
        "review",
        "number",
        "conference",
        "call",
        "follows",
        "u",
        "participant",
        "international",
        "participant",
        "conference",
        "id",
        "clovis",
        "oncology",
        "clovis",
        "oncology",
        "biopharmaceutical",
        "company",
        "focused",
        "acquiring",
        "developing",
        "commercializing",
        "innovative",
        "agent",
        "europe",
        "additional",
        "international",
        "market",
        "clovis",
        "oncology",
        "target",
        "development",
        "program",
        "specific",
        "subset",
        "cancer",
        "population",
        "simultaneously",
        "develops",
        "partner",
        "diagnostic",
        "tool",
        "intended",
        "direct",
        "compound",
        "development",
        "population",
        "likely",
        "benefit",
        "use",
        "clovis",
        "oncology",
        "headquartered",
        "boulder",
        "colorado",
        "additional",
        "office",
        "san",
        "francisco",
        "california",
        "cambridge",
        "uk",
        "please",
        "visit",
        "information",
        "view",
        "source",
        "version",
        "http",
        "clovis",
        "oncology",
        "investor",
        "contact",
        "anna",
        "sussman",
        "asussman",
        "breanna",
        "burkart",
        "bburkart",
        "source",
        "clovis",
        "oncology",
        "inc"
    ]
}